Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Express Scripts
McKesson
Boehringer Ingelheim
Harvard Business School

Last Updated: August 17, 2022

CLINICAL TRIALS PROFILE FOR CEVIMELINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Cevimeline Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00017511 ↗ Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed Daiichi Sankyo Inc. Phase 3 2001-06-01 RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer.
NCT00017511 ↗ Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed Daiichi Sankyo, Inc. Phase 3 2001-06-01 RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer.
NCT00466388 ↗ Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia Completed Duke University Phase 4 2007-05-01 The purpose of this study is to determine the effectiveness of cevimeline (versus placebo) on the oral health of patients who have dry mouth which was caused by radiation therapy that was given for treatment of head and/or neck cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cevimeline Hydrochloride

Condition Name

Condition Name for Cevimeline Hydrochloride
Intervention Trials
Dry Mouth 3
Sjogren's Syndrome 1
Xerostomia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cevimeline Hydrochloride
Intervention Trials
Xerostomia 4
Head and Neck Neoplasms 1
Urinary Bladder, Overactive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cevimeline Hydrochloride

Trials by Country

Trials by Country for Cevimeline Hydrochloride
Location Trials
United States 43
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cevimeline Hydrochloride
Location Trials
Kentucky 3
Virginia 2
Pennsylvania 2
Kansas 2
Illinois 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cevimeline Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cevimeline Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cevimeline Hydrochloride
Clinical Trial Phase Trials
Completed 5
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cevimeline Hydrochloride

Sponsor Name

Sponsor Name for Cevimeline Hydrochloride
Sponsor Trials
Roxane Laboratories 2
Daiichi Sankyo Inc. 1
Daiichi Sankyo, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cevimeline Hydrochloride
Sponsor Trials
Industry 4
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Express Scripts
Merck
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.